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Background: The objective of this study was to evaluate the influence of clinical-pathological and sociodemo-
graphic factors on the prevalence of distant metastasis (DM) and overall survival in patients with oral cavity and 
oropharynx squamous cell carcinoma (OOSCC).
Material and Methods: Cross-sectional study based on the records of 404 OOSCC patients evaluated for DM, cov-
ering the period 2000-2014. We analysed the influence of age, sex, level of schooling, primary tumor subsite, treat-
ment, marital status, family history of cancer, history of smoking and alcohol consumption, type of health care 
coverage (private vs. public) and overall survival. Findings were submitted to Fisher’s exact test, Pearson’s chi-
squared test, Mantel-Cox log-rank testing and multinomial and Cox regression analysis (SPSS v. 20.0; p<0.05).
Results: The prevalence of DM was 5.4% (22/404). The respiratory tract was the most affected DM site (n=9; 
40.9%). Male sex (p=0.049), oropharyngeal primary tumor (p=0.008), stage T3-4 (p=0.022), lymph node metas-
tasis (N+) (p<0.001) and palliative treatment (p=0.005) were directly associated with DM. Patients with oral pri-
mary tumours (p=0.343) and primary oropharyngeal tumours (p=0.242) did not differ significantly with regard to 
the prevalence of DM. N+ was an independent risk factor for DM (p=0.017). Five variables independently reduced 
overall survival: male sex (p=0.035), age >65 years (p=0.046), indigenous/brown racial type (p=0.045), palliative 
treatment (p=0.035) and DM (p=0.048).
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Introduction
Oral cavity and oropharynx squamous cell carcinoma 
(OOSCC) have become a major health concern among 
public health authorities worldwide due to its high in-
cidence, prevalence and mortality (1). Oral cancer is 
the sixth-most common type of cancer in the world. In 
Brazil, the Latin American country with the highest 
prevalence of OOSCC, it is currently the seventh-most 
common type of cancer (2).
Approximately 90% of neoplasms affecting the oral 
cavity and oropharynx are squamous cell carcinomas 
(3). Affected regions include the lips, buccal mucosa, 
gums, hard palate, tongue, oral floor, tonsils, soft palate, 
tongue base, salivary glands, retromolar trigone, vallec-
ula, tonsillar arches, palatine tonsils and the posterior 
and lateral walls of the oropharynx (4).
On average, patients diagnosed with OOSCC survive 
for 5 years (5). The main factor involved in the onset of 
OOSCC is smoking (6), but the incidence of OOSCC 
has also been shown to be associated with human pap-
illomavirus (HPV). In the Brazilian population, men 
are more susceptible than women, although in general 
prognosis appears to be better (4). According to the lit-
erature, the clinical-pathological profile of patients with 
OOSCC is typically male sex, age between 50 and 60 
years, and history of smoking. The anatomical site most 
frequently affected by OOSCC is the tongue and oral 
floor (4).
OOSCC may be treated with radiotherapy, chemothera-
py or surgery, or a combination of these. Treatment and 
prognosis depend on tumor subsite, time of discovery 
and staging. Prognosis requires stage grouping based on 
the characteristics of the primary tumor, lymph nodes 
and systemic metastases (7).
The cervical lymph nodes are the main site of metastasis 
(7) but, since little has been published on sites of involve-
ment in OOSCC, the possibility of distant metastases 
(DM) should be considered. The prevalence of OOSCC-
related DMs in the lungs and bones ranges from 52% to 
83% (8,9). The mean time between symptom onset and 
detection of the first DM is ~16 months. Once DMs have 
been identified, the mean survival time is ~5 months (10).
DMs may be detected concurrently with the primary le-
sion or after treatment (11), and high T and N stages are 
important risk factors for DM (8). Since the presence of 
DMs has a strong impact on the prognosis of OOSCC 
patients (7), the ability to identify risk factors for DM is 
indispensable for care providers at cancer centers. The 
objective of the present study was therefore to evalu-
ate the influence of clinical-pathological and sociode-
mographic factors on the prevalence of DM and overall 
survival in OOSCC patients.
Material and Methods 
- Type of study and study population
This retrospective study was based on the medical re-
cords of 404 OOSCC patients diagnosed and treated at 
a cancer referral center in Northeastern Brazil (Hospi-
tal Haroldo Juaçaba, Ceará Cancer Institute) between 
1 January 2000 and 31 December 2014. Only patients 
with complete TNM clinical staging were included. Pa-
tients staged M1 but without identification of the DM 
site were excluded from the sample. All patient infor-
mation was retrieved from the institution’s digital can-
cer registry.
- Study variables
The sociodemographic variables included age, sex, 
racial type, schooling, marital status, family history, 
history of smoking and alcohol consumption, and type 
of health care coverage (public vs. private). The clini-
cal variables included histological type, tumor subsite, 
TNM staging, tumor staging, and treatment(s) admin-
istered. Overall survival (expressed in months) was 
defined as the time from the beginning of treatment 
(day/month/year) to death (day/month/year) or the last 
follow-up visit (day/month/year) (11).
- Statistical analysis
All statistical analyses were performed with the soft-
ware IBM SPSS Statistics for Windows (v. 20.0), using 
a 95% confidence interval.
We employed Fisher’s exact test, Pearson’s chi-squared 
test and multinomial logistic regression modelto evalu-
ate the factors associated with DM and 15-year surviv-
al. Kaplan-Meier curves were plotted to determine the 
mean and standard error of overall survival, which was 
then submitted to Mantel-Cox log-rank test and Cox re-
gression analysis. All the variables were included in the 
multivariate models.
Results
- Clinical and sociodemographic description of meta-
static OOSCC
Twenty-two (5.4%) of the 404 OOSCC patients with 
available TNM staging had metastases. The DMs were 
Conclusions: Lymph node metastasis independently increased the prevalence of DM and, along with male sex, older 
age, brown racial type and palliative treatment, was independently associated with poor prognosis in patients with 
OOSCC.
Key words: Neoplasm metastasis, mouth neoplasms, prognosis, carcinoma, squamous cell.
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years old and 47.0% (n=190) were over 65, but the two 
age groups did not differ significantly with regard to the 
presence of DMs. Most patients (n=256; 63.4%) were 
of brown racial type, predominantly with incomplete 
elementary school education (n=99; 31.7%). However, 
none of the variables above had any influence on the 
outcome of DM (Table 1).
located in the trachea/bronchi/lungs (n=9; 40.9%), 
brain (n=6; 27.3%), bone/joint/articular cartilage (n=5; 
22.7%), larynx (n=1; 4.5%) or liver (n=1; 4.5%).
The sample included significantly more males (n=290; 
71.8%) than females (n=114; 28.8%). Moreover, males 
were more prone to develop DMs (p=0.049). Segregat-
ing the patients by age, 53.0% (n=214) were up to 65 
Table 1: Influence of clinical and sociodemographic characteristics of distant metastases (DM) in patients with squamous cell carcinoma of the 
mouth and oropharynx (OOSCC) treated at Hospital Haroldo Juaçaba (Ceará Cancer Institute) between 1 January 2000 and 31 December 2014. 
Total M p-Value0 1
Total 404 (100.0%) 382 (94.6%) 22 (5.4%) -
Gender Female 114 (28.2%) 112 (29.3%)* 2 (9.1%) 0.049
Male 290 (71.8%) 270 (70.7%) 20 (90.9%)*
Age Up to 65 years old 214 (53.0%) 201 (52.6%) 13 (59.1%) 0.554
Older than 65 190 (47.0%) 181 (47.4%) 9 (40.9%)
Race White 148 (36.6%) 139 (36.4%) 9 (40.9%) 0.669
Brown 256 (63.4%) 243 (63.6%) 13 (59.1%)
Schooling degree
Illiterate 86 (27.6%) 80 (27.3%) 6 (31.6%) 0.673
Elementary school (unfinished) 99 (31.7%) 95 (32.4%) 4 (21.1%)
Elementary school (finished) 83 (26.6%) 78 (26.6%) 5 (26.3%)
Secondary school (finished) 44 (14.1%) 40 (13.7%) 4 (21.1%)
Anatomical site Mouth 351 (86.9%) 336 (88.0%)* 15 (68.2%) 0.008
Oropharynx 53 (13.1%) 46 (12.0%) 7 (31.8%)*
Mouth tumors
Tongue 150 (42.7%) 144 (42.9%) 6 (40.0%) 0.343
Palate 69 (19.7%) 67 (19.9%) 2 (13.3%)
Retromolar 53 (15.1%) 50 (14.9%) 3 (20.0%)
Oral floor 45 (12.8%) 42 (12.5%) 3 (20.0%)
Lip 12 (3.4%) 12 (3.6%) 0 (0.0%)
Jugal mucosa 18 (5.1%) 18 (5.4%) 0 (0.0%)
Gingiva 4 (1.1%) 3 (0.9%) 1 (6.7%)
Oropharyngeal 
Tumors
Lateral wall of the oropharynx 32 (60.4%) 26 (56.5%) 6 (85.7%) 0.242
Posterior wall of the oropharynx 13 (24.5%) 13 (28.3%) 0 (0.0%)
Epiglottis 8 (15.1%) 7 (15.2%) 1 (14.3%)
T T1-T2 224 (55.4%) 217 (56.8%)* 7 (31.8%) 0.022
T3-T4 180 (44.6%) 165 (43.2%) 15 (68.2%)*
N N0 285 (70.5%) 277 (72.5%)* 8 (36.4%) <0.001
N+ 119 (29.5%) 105 (27.5%) 14 (63.6%)*
Treatment
None 55 (13.6%) 48 (12.6%) 7 (31.8%)* 0.005
Surgery 48 (11.9%) 48 (12.6%)* 0 (0.0%)
Surgery + RT 97 (24.0%) 95 (24.9%)* 2 (9.1%)
Surgery + RT + CT 21 (5.2%) 21 (5.5%)* 0 (0.0%)
RT 100 (24.8%) 96 (25.1%)* 4 (18.2%)
RT + CT 83 (20.5%) 74 (19.4%) 9 (40.9%)*
Marriage status No 345 (85.4%) 325 (85.1%) 20 (90.9%) 0.755
Yes 59 (14.6%) 57 (14.9%) 2 (9.1%)
Family history No 332 (82.2%) 314 (82.2%) 18 (81.8%) 1.000
Yes 72 (17.8%) 68 (17.8%) 4 (18.2%)
Alcohol history No 260 (64.4%) 248 (64.9%) 12 (54.5%) 0.323
Yes 144 (35.6%) 134 (35.1%) 10 (45.5%)
Smoker history No 237 (58.7%) 223 (58.4%) 14 (63.6%) 0.626
Yes 167 (41.3%) 159 (41.6%) 8 (36.4%)
Referral Private health plans 188 (46.5%) 180 (47.1%) 8 (36.4%) 0.383
Public health system 216 (53.5%) 202 (52.9%) 14 (63.6%)
*p<0.05, Fisher’s exact test or Pearson’s chi-squared test. DM=distant metastasis; RT=radiotherapy; CT=chemotherapy.
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The most frequent tumor site was the mouth (n=351; 
86.9%), followed by the oropharynx (n=53; 13.1%). 
Nevertheless, the oropharyngeal region accounted for 
significantly more cases with DMs (p=0.008). Most tu-
mors (55.4%) were classified as T1-T2, but patients with 
T3-T4 had a higher prevalence of DM (p=0.022). No 
lymph node metastases (N0) were observed in the ma-
jority of patients (70.5%), but patients with this finding 
had a higher prevalence of DM (p<0.001) (Table 1).
Radiotherapy was the most frequently administered 
treatment (n=100; 24.8%), followed by the combina-
tion of surgery plus radiotherapy (n=97, 24.0%), and 
the combination of radiotherapy plus chemotherapy 
(n=83; 20.5%). Palliative treatment (n=55; 13.6%) and 
the combination of radiotherapy and chemotherapy 
(n=83, 20.5%) were significantly associated with DM 
(p=0.005) when compared to other treatment modali-
ties (Table 1).
Most patients were unmarried (n=345; 85.4%) and/or 
had no family history of cancer (n=332; 82.2%), no his-
tory of smoking (n=237; 58.7%) and no history of al-
coholism (n=260; 64.4%). Slightly more than half were 
covered by private health insurance (n=216; 53.5%). 
None of these variables were significantly associated 
with the presence of DMs (p>0.05) (Table 1).
The most common subsite of oral tumors was the tongue 
(n=150; 42.7%), while oropharyngeal tumors were most 
often located in the lateral wall region (n=32; 60.4%). 
Patients with oral tumors (p=0.343) and patients with 
oropharyngeal tumors (p=0.242) did not differ signifi-
cantly with regard to the prevalence of DMs (Table 1).
Following the multivariate analysis, the only variable 
which remained independently associated with the 
presence DMs was lymph node metastasis (p=0.017), 
corresponding to an increase in the prevalence of DM 
by a factor of 3.16 (Table 2).
- Prognostic factors: analysis of 15-year survival
After 15 years of evaluation, the survival rate was 
46.8% (n=189) and the mean overall survival was 85 ± 4 
months. Half the patients (median) had died 47 months 
into the study period (Fig. 1).
 p-Value Adjusted OR (95% CI)
M1
Gender (Male vs. Female) 0.113 -
Age(>65 years old vs. <65 years old) 0.546 -
Race (Brown vs. White) 0.163 -
Schooling degree (Illiterate vs. Literate) 0.272 -
Anatomical site (Oropharynx vs. Mouth) 0.075 -
T (T3/4 vs. T1/2) 0.154 -
N (N+ vs. N0) 0.017* 3.16 (1.23 - 8.10)
Treatment (Surgical vs. non-Surgical) 0.315 -
Marriage bond (Yes vs. No) 0.476 -
Family history (Yes vs. No) 0.267 -
Alcohol (Yes vs. No) 0.263 -
Smoking (Yes vs. No) 0.101 -
Referral (Private health plan vs. Public health system) 0.901 -
*p<0.05, multinomial logistic regression. OR=odds ratio; CI=confidence interval; DM=distant metastasis.
Table 2: Multivariate analysis of risk factors for distant metastasis (DM) in patients with squamous cell carcinoma of 
the mouth and oropharynx (OOSCC) treated at Hospital Haroldo Juaçaba (Ceará Cancer Institute) between 1 January 
2000 and 31 December 2014.
The overall survival prevalence and the mean sur-
vival time were significantly better in female patients 
(p=0.001; p=0.006), in younger patients (≤65 years) 
(p=0.018; p=0.024) and in patients of white racial type 
(p=0.043; p=0.039), respectively. The level of school-
ing influenced the overall 15-year survival: the rate was 
higher for patients with complete elementary or high 
school education (p=0.049), but the mean survival time 
did not vary significantly (p=0.626). Likewise, survival 
rates were higher for patients with oropharyngeal tu-
mors than for patients with oral tumors (p=0.007), with 
no difference in mean survival time (p=0.087) (Table 3).
Fig. 1: 15-year follow-up and global survival of patients with squa-
mous cell carcinoma of the oral cavity and oropharynx (OOSCC) 
treated at Hospital Haroldo Juaçaba (Ceará Cancer Institute) between 
1 January 2000 and 31 December 2014 (Kaplan-Meier method).
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Female 68 (59.6%)* 0.001a 95.2±7.3* 0.006b
Male 121 (41.7%) 78.2±4.9
Age
Up to 65 years old 112 (52.3%)* 0.018a 95.1±6.0* 0.024b
Older than 65 77 (40.5%) 74.3±5.9
Race
White 79 (53.4%)* 0.043a 96.9±7.2* 0.039b
Brown 110 (43.0%) 78.5±5.3
Schooling 
degree
Illiterate 33 (38.4%) 0.049a 72.4±7.5 0.626b
Elementary school (unfinished) 38 (38.4%) 76.6±7.9
Elementary school (finished) 46 (55.4%)* 83.2±9.4
Secondary school (finished) 23 (52.3%)* 93.8±13.2
Anatomical site
Mouth 155 (44.2%) 0.007a 82.0±4.5 0.087b
Oropharynx 34 (64.2%)* 108.4±12.5
T
T1-T2 115 (51.3%)* 0.041a 93.5±5.9* 0.037b
T3-T4 74 (41.1%) 75.2±6.1
N
N0 134 (47.0%) 0.883a 87.5±5.0 0.170b
N+ 55 (46.2%) 81.3±8.2
M
0 181 (47.4%) 0.314a 86.2±4.4 0.061b
1 8 (36.4%) 59.6±16.2
Treatment
None 25 (45.5%) 0.047a 78.9±10.2 0.001b
Surgery 29 (60.4%)* 113.4±12.0*
Surgery + RT 50 (51.5%)* 98.2±8.2
Surgery + RT + CT 8 (38.1%) 42.8±8.9
RT 35 (35.0%) 56.5±7.4
RT + CT 42 (50.6%) 88.6±10.0
Marriage status
No 158 (45.8%) 0.337a 84.2±4.6 0.472b
Yes 31 (52.5%) 85.5±9.8
Family history
No 145 (43.7%) 0.009a 81.7±4.6 0.081b
Yes 44 (61.1%)* 104.5±10.4
Alcohol history
No 111 (42.7%) 0.054a 81.9±5.1 0.231b
Yes 78 (54.2%) 75.0±5.5
Smoker history
No 104 (43.9%) 0.164a 83.8±5.4 0.675b
Yes 85 (50.9%) 72.0±5.0
Referral
Private health plans 90 (47.9%) 0.682a 80.4±5.5 0.720b
Public health system 99 (45.8%) 83.8±5.8
*p<0.05; aChi-squared test or Fisher’s exact test (results expressed as absolute and percentage frequency); bMantel-Cox log-rank test (results 
expressed as mean ± SEM); DM=distant metastasis; RT=radiotherapy; CT=chemotherapy.
Table 3: Influence of clinical and sociodemographic variables on the overall survival of patients with squamous cell carcinoma of the mouth and 
oropharynx (OOSCC) treated at Hospital Haroldo Juaçaba (Ceará Cancer Institute) between 1 January 2000 and 31 December 2014.
Patients with T1-T2 tumors had a higher survival rate 
(p=0.041) and a longer survival time (p=0.037) than did 
patients with T3-T4 tumors. The presence of lymph node 
metastasis and DM was not significantly associated with 
survival rate or mean survival time (p>0.05). As for treat-
ment form, survival rate (p=0.047) and survival time 
(p=0.001) were better for patients treated with surgery or 
with a combination of surgery and radiotherapy than for 
patients who received other treatment modalities (Table 3).
Marital status, history of alcohol consumption and 
smoking, and type of health care coverage had no sig-
nificant influence on survival rate or time (Table 3). The 
survival rate was higher for patients with than without 
family history of cancer (p=0.009).
In the multivariate analysis, five variables indepen-
dently reduced overall survival: male sex (HR=1.55; 
p=0.035), age >65 years (HR=1.39; p=0.046), brown 
racial type (HR=1.42; p=0.045), non-surgical treatment 
(HR=1.11; p=0.035) and DM (HR=1.71; p=0.048), which 
displayed the highest hazard risk (Table 4).
e380
Med Oral Patol Oral Cir Bucal. 2020 May 1;25 (3):e375-82. Prognosis and risk factors for metastatic OOSCC
Discussion
In the present study, we drew the clinical-pathological 
and sociodemographic profile of 404 OOSCC patients 
evaluated for the presence of DM. The prevalence of 
DM was 5.5%, matching findings in the literature, al-
though percentages may be underestimated depending 
on sample size. Thus, in a study involving over 1,000 
patients, the prevalence of DM was 9.6%. Variations in 
prevalence may also depend on whether the mouth and 
oropharynx were evaluated together, as in this study (9).
DM affected the lower airways in 40.9% of our patients. 
Another observational study found 50% of DMs to 
involve the lungs, making that structure the main tar-
get. Although sites other than the lungs were affected 
in more than half our patients with DM, the lungs ap-
pear to be the primary site of DM involvement (10). The 
next-most prevalent sites of OOSCC-related DM were 
the central nervous system (27.3%) and bone tissue 
(22.7%). In another retrospective study, DMs targeted 
bone tissue in 34% of cases, indicating the need for 
bone evaluation in patients with high staging (8), espe-
cially since stage T3 and T4 tumors are associated with 
higher prevalence of DM.
Previous studies have shown tumor extension to be in-
dependently associated with the risk of DM (12), espe-
cially for tumors in the hypopharynx and supraglottis 
(9). In our sample, patients with oropharyngeal tumors 
were more likely to have DM than patients with oral tu-
mors, supporting the notion that the presence of prima-
ry tumors in the lower neck structures is a risk factor for 
DM (10). The greater likelihood of DMs in patients with 
oropharyngeal tumors may be explained by the greater 
difficulty of evaluating the lower neck area for primary 
tumors, but it should also be kept in mind that the lower 
structures are more vascularized and have better lymph 
node connectivity (10). In our study, the presence of 
lymph node metastases was an independent risk factor 
for DM, suggesting that lymph node involvement may 
contribute to disease dissemination. Lymph node in-
volvement is reported to be less frequent in HPV-related 
OOSCC (4). We did not evaluate HPV infection in this 
study, but the strong association observed between the 
oropharynx and DM points to other risk factors, such as 
smoking and alcohol consumption.
The fact that approximately 50% of patients with head 
and neck SCC have positive lymph nodes at diagnosis 
shows the need for DM investigation, especially since 
the presence of DMs significantly reduces survival (13-
15). Lymph node involvement is the most important risk 
factor for OOSCC recurrence (7) and in this study was 
the only risk factor for DM.
Another risk factor for DM is male sex. This is con-
sistent with previous studies (8), although the distribu-
tion seems to depend on the population evaluated (10). 
Perea et al. suggest the distribution is influenced by the 
timeliness of diagnosis, which in many settings occurs 
earlier in women (16).
As shown above, the most prevalent subsites were the 
tongue (oral tumors) and the lateral wall (oropharyngeal 
tumors), but the subsite had no significant influence on 
 p-Value Adjusted HR for dead(95% CI)
Variables
Gender (Male vs. Female) 0.035 1.55 (1.03-2.33)
Age (>65 years old vs. <65 years old) 0.046 1.39 (1.01-1.93)
Race (Brown vs. White) 0.045 1.42 (1.01-2.01)
Schooling degree (Illiterate vs. Literate) 0.445 -
Anatomical site (Oropharynx vs. Mouth) 0.120 -
T (T3/4 vs. T1/2) 0.438 -
N (N+ vs. N0) 0.695 -
M (M1 vs. M0) 0.048 1.71 (1.01-3.23)
Treatment (Surgical vs. non-Surgical) 0.035 1.11 (1.02-1.22)
Marriage bond (Yes vs. No) 0.563 -
Family history (Yes vs. No) 0.938 -
Alcohol (Yes vs. No) 0.184 -
Smoking (Yes vs. No) 0.349 -
Referral (Private health plan vs. Public health system) 0.778 -
*p<0.05, Cox regression; HR=hazard risk; CI=confidence interval. T=T stage; N=N stage; M=M stage.
Table 4: Multivariate analysis and independent risk factors for poor survival in patients with squamous cell carcinoma 
of the oral cavity and oropharynx (OOSCC) treated at Hospital Haroldo Juaçaba (Ceará Cancer Institute) between 1 
January 2000 and 31 December 2014.
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the prevalence of DM. This diverges from the results of 
another study showing that the lower and more poste-
rior the subsite, the higher the risk of DM (9).
In this study, the 15-year survival rate of patients with 
OOSCC was 46.8%. This is somewhat better than would 
be expected based on the results of Moro et al. who reg-
istered survival rates of 42% and 38% at 5 and 10 years, 
respectively (5), and Köhler et al. who reported 53.42% 
overall survival for a sample with a mean follow-up of 
44 months (7). Prognosis is even worse in some popula-
tions: in southern Thailand the survival rate was 24.1% 
at 5 years and 25.95% at 10 years. The authors attributed 
these figures to the more advanced stage at which their 
patients were diagnosed and to the treatments adminis-
tered (17).
Socioeconomic status plays a key role in survival statis-
tics. Most of our patients were covered by private health 
insurance (potentially favoring survival), but in earlier 
investigations on similar populations conducted by our 
group, the level of schooling and history of smoking 
were the main determinants of poor prognosis (11,18). 
Individuals of low socioeconomic status tend to have 
limited access to health services and to be less aware 
of risk factors, which in turn increases the risk of late 
prognosis and shortens survival. More effective public 
health policies are required to change this unfortunate 
scenario characteristic of countries with high income 
concentration.
The main determinants of good prognosis in our sam-
ple were female sex, age <65 years and complete high 
school education. This is compatible with previous 
studies arguing that men are generally more prone to 
smoking and alcoholism. Low levels of schooling may 
be associated with lack of health awareness, limited ac-
cess to health services, increased risk of malnutrition, 
and greater exposure to OOSCC risk factors (4,10,19).
Some authors have concluded that marital status has 
a significant impact on the prognosis of OOSCC (20), 
but no such association was observed in our study. In 
contrast, in our sample the protective factors were fe-
male sex, age <65 years, white racial type, high level 
of schooling, oropharyngeal subsite, T1-T2 staging, 
and surgical treatment. However, in the multivariate 
analysis, only male sex, older age, brown racial type, 
palliative treatment, and DM were associated with poor 
prognosis, with DM presenting the highest risk of death.
Thus, despite the limited sample size and retrospective 
nature of our study, we observed that male patients with 
oropharyngeal cancer classified as N+ present a higher 
prevalence of DM, which is the factor most strongly as-
sociated with poor overall survival. Based on this, we 
recommend submitting patients with N+ OOSCC to 
systemic evaluation for early detection of DMs, thereby 
potentially improving prognosis.
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